当前位置: X-MOL 学术ACS Med. Chem. Lett. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A Phosphoramidate Strategy Enables Membrane Permeability of a Non-nucleotide Inhibitor of the Prolyl Isomerase Pin1.
ACS Medicinal Chemistry Letters ( IF 3.5 ) Pub Date : 2020-08-10 , DOI: 10.1021/acsmedchemlett.0c00170
Daniel M C Schwarz 1 , Sarah K Williams 1 , Maxwell Dillenburg 2 , Carston R Wagner 2 , Jason E Gestwicki 1
Affiliation  

The membrane permeability of nucleotide-based drugs, such as sofosbuvir (Sovaldi), requires installation of phosphate-caging groups. One strategy, termed “ProTide”, masks the anionic phosphate through an N-linked amino ester and an O-linked aromatic phospho-ester, such that release of the active drug requires consecutive enzymatic liberation by an esterase and then a phosphoramidase, such as Hint1. Because Hint1 is known to be selective for nucleotides, it was not clear if the ProTide approach could be deployed for non-nucleotides. Here, we demonstrate that caging of a phosphate-containing inhibitor of the prolyl isomerase Pin1 increases its permeability. Moreover, this compound was processed by both esterase and phosphoramidase activity, releasing the active molecule to bind and inhibit Pin1 in cells. Thus, Hint1 appears to recognize a broader set of substrates than previously appreciated. It seems possible that other potent, but impermeable, phosphate-containing inhibitors might likewise benefit from this approach.

中文翻译:


氨基磷酸酯策略使脯氨酰异构酶 Pin1 的非核苷酸抑制剂具有膜通透性。



核苷酸类药物(例如索非布韦(Sovaldi))的膜渗透性需要安装磷酸盐封闭基团。一种称为“ProTide”的策略通过N-连接的氨基酯和O-连接的芳香族磷酸酯掩盖阴离子磷酸盐,使得活性药物的释放需要通过酯酶和随后的磷酸酰胺酶连续酶促释放,例如提示1.由于已知 Hint1 对核苷酸具有选择性,因此尚不清楚 ProTide 方法是否可以应用于非核​​苷酸。在这里,我们证明了脯氨酰异构酶 Pin1 的含磷酸盐抑制剂的笼罩会增加其通透性。此外,该化合物经过酯酶和磷酸酰胺酶活性处理,释放活性分子结合并抑制细胞中的 Pin1。因此,Hint1 似乎能够识别比之前认识的更广泛的底物。其他有效但不可渗透的含磷酸盐抑制剂似乎也可能从这种方法中受益。
更新日期:2020-09-10
down
wechat
bug